Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.2484 USD
−55.20 M USD
19.31 M USD
13.65 M
About Turnstone Biologics Corp.
Sector
Industry
CEO
Sammy J. Farah
Website
Headquarters
La Jolla
Founded
2015
FIGI
BBG011J1H914
Turnstone Biologics Corp. operates as a clinical stage biotechnology company. It engages in the business of developing and commercializing therapeutics. The company is focused on developing new medicines to treat and cure patients with solid tumors. Turnstone Biologics was founded in 2015 and is headquartered in La Jolla, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TSBX is 0.5188 USD — it has increased by 2.73% in the past 24 hours. Watch Turnstone Biologics Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Turnstone Biologics Corp. stocks are traded under the ticker TSBX.
TSBX stock has risen by 10.38% compared to the previous week, the month change is a 1.73% rise, over the last year Turnstone Biologics Corp. has showed a −77.73% decrease.
We've gathered analysts' opinions on Turnstone Biologics Corp. future price: according to them, TSBX price has a max estimate of 3.75 USD and a min estimate of 0.40 USD. Watch TSBX chart and read a more detailed Turnstone Biologics Corp. stock forecast: see what analysts think of Turnstone Biologics Corp. and suggest that you do with its stocks.
TSBX reached its all-time high on Jul 31, 2023 with the price of 13.2000 USD, and its all-time low was 0.4393 USD and was reached on Oct 10, 2024. View more price dynamics on TSBX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TSBX stock is 5.00% volatile and has beta coefficient of 0.34. Track Turnstone Biologics Corp. stock price on the chart and check out the list of the most volatile stocks — is Turnstone Biologics Corp. there?
Today Turnstone Biologics Corp. has the market capitalization of 11.68 M, it has decreased by −4.24% over the last week.
Yes, you can track Turnstone Biologics Corp. financials in yearly and quarterly reports right on TradingView.
Turnstone Biologics Corp. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
TSBX earnings for the last quarter are −0.74 USD per share, whereas the estimation was −0.86 USD resulting in a 13.95% surprise. The estimated earnings for the next quarter are −0.85 USD per share. See more details about Turnstone Biologics Corp. earnings.
Turnstone Biologics Corp. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
TSBX net income for the last quarter is −17.03 M USD, while the quarter before that showed −21.30 M USD of net income which accounts for 20.05% change. Track more Turnstone Biologics Corp. financial stats to get the full picture.
No, TSBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 30, 2024, the company has 80.00 employees. See our rating of the largest employees — is Turnstone Biologics Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Turnstone Biologics Corp. EBITDA is −77.35 M USD, and current EBITDA margin is −286.61%. See more stats in Turnstone Biologics Corp. financial statements.
Like other stocks, TSBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Turnstone Biologics Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Turnstone Biologics Corp. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Turnstone Biologics Corp. stock shows the neutral signal. See more of Turnstone Biologics Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.